Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453065 | Hematology/Oncology and Stem Cell Therapy | 2016 | 6 Pages |
Abstract
The yield of CTPA to rule out PE in patients with cancer presenting in the ED is low. Following a validated decision-making protocol such as Wells Criteria may significantly decrease the number of CTPA used in the ED.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Pierre Tannous, Zubin Mukadam, Chetan Kammari, Harsha Banavasi, Ayman O. Soubani,